Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $15.11 $17.90 Friday, 10th May 2024 ACAD stock ended at $15.25. This is 0.263% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.78% from a day low at $15.11 to a day high of $15.53.
90 days $15.11 $26.78
52 weeks $15.11 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Oct 21, 2016 $25.34 $25.34 $25.34 $25.34 6 917 300
Oct 20, 2016 $23.95 $23.95 $23.95 $23.95 1 951 400
Oct 19, 2016 $23.41 $23.41 $23.41 $23.41 2 211 100
Oct 18, 2016 $24.33 $24.33 $24.33 $24.33 2 027 500
Oct 17, 2016 $24.33 $24.33 $24.33 $24.33 2 743 200
Oct 14, 2016 $23.67 $23.67 $23.67 $23.67 3 801 500
Oct 13, 2016 $25.19 $25.19 $25.19 $25.19 2 438 600
Oct 12, 2016 $25.78 $25.78 $25.78 $25.78 2 568 900
Oct 11, 2016 $26.88 $26.88 $26.88 $26.88 2 795 900
Oct 10, 2016 $27.21 $27.21 $27.21 $27.21 1 772 900
Oct 07, 2016 $26.86 $26.86 $26.86 $26.86 3 659 400
Oct 06, 2016 $27.39 $27.39 $27.39 $27.39 3 013 700
Oct 05, 2016 $28.81 $28.81 $28.81 $28.81 1 928 600
Oct 04, 2016 $29.10 $29.10 $29.10 $29.10 5 290 000
Oct 03, 2016 $30.71 $30.71 $30.71 $30.71 2 725 500
Sep 30, 2016 $31.81 $31.81 $31.81 $31.81 2 357 600
Sep 29, 2016 $32.70 $32.70 $32.70 $32.70 3 295 700
Sep 28, 2016 $33.68 $33.68 $33.68 $33.68 3 620 200
Sep 27, 2016 $35.23 $35.23 $35.23 $35.23 1 317 900
Sep 26, 2016 $34.30 $34.30 $34.30 $34.30 1 254 500
Sep 23, 2016 $34.98 $34.98 $34.98 $34.98 1 488 800
Sep 22, 2016 $34.98 $34.98 $34.98 $34.98 2 045 700
Sep 21, 2016 $35.62 $35.62 $35.62 $35.62 2 823 400
Sep 20, 2016 $35.98 $35.98 $35.98 $35.98 3 318 700
Sep 19, 2016 $34.82 $34.82 $34.82 $34.82 2 144 700
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT